TapewireFind a company

person · Reporting owner

FRANK MORGAN C.

Disclosed activity across 6 companies

Tapewire entity
32790
SEC CIK
0001593072

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
BRAIN SCIENTIFIC INC.BRSF · Entity 12425610% ownerJune 15, 2022August 04, 2022
Modular Medical, Inc.MODD · Entity 7488Director · 10% ownerSeptember 30, 2026October 01, 2026
NEUROONE MEDICAL TECHNOLOGIES CorpNMTC · Entity 780810% ownerJanuary 15, 2021January 21, 2021
SANUWAVE Health, Inc.SNVW · Entity 7321Director · Chief Executive OfficerSeptember 30, 2026October 03, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, $0.001 par valueSEC Table I · non-derivativeIndirectSee Footnote19,545,187 Reported balance Holding disclosure · report date 2022-06-15 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 19,545,187

F1: The reported securities and warrants are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Common Stock, $0.001 par valueSEC Table I · non-derivativeIndirectSee Footnote12,816,831 Reported balance Holding disclosure · report date 2022-06-15 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 12,816,831

F2: The reported securities and warrants are owned directly by JEB Partners, L.P. ("JEB Partners") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Common Stock, $0.001 par valueSEC Table I · non-derivativeDirect8,028,706 Reported balance Holding disclosure · report date 2022-06-15 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 8,028,706

F3: The reported securities and warrants are directly owned by James E. Besser in his personal capacity.

Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.25IndirectSee FootnoteNot disclosed Reported balance Holding disclosure · report date 2022-06-15 · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · Balance Not disclosed

F4: The reported warrants are exercisable as of the issue date, subject to certain conditions.

F5: The reported warrants expire at 5:00pm E.D.T. on the fourth anniversary of the issue date, subject to certain conditions.

F1: The reported securities and warrants are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.25IndirectSee FootnoteNot disclosed Reported balance Holding disclosure · report date 2022-06-15 · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · Balance Not disclosed

F4: The reported warrants are exercisable as of the issue date, subject to certain conditions.

F5: The reported warrants expire at 5:00pm E.D.T. on the fourth anniversary of the issue date, subject to certain conditions.

F2: The reported securities and warrants are owned directly by JEB Partners, L.P. ("JEB Partners") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.25DirectNot disclosed Reported balance Holding disclosure · report date 2022-06-15 · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · Balance Not disclosed

F4: The reported warrants are exercisable as of the issue date, subject to certain conditions.

F5: The reported warrants expire at 5:00pm E.D.T. on the fourth anniversary of the issue date, subject to certain conditions.

F3: The reported securities and warrants are directly owned by James E. Besser in his personal capacity.

Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.35 · Expires 2031-10-01DirectNot disclosed Reported balance Holding disclosure · report date 2022-06-15 · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · Balance Not disclosed

F6: The reported warrants are subject to a blocker provision that prevents James E. Besser from exercising the warrants if he would be more than a 4.99% beneficial owner of the Common Stock, $0.001 par value, following such exercise. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to the Common Stock Purchase Warrant included as Exhibit 4.1 of the Issuer's 8-K filed on October 7, 2021, which is incorporated by reference.

F3: The reported securities and warrants are directly owned by James E. Besser in his personal capacity.

Filing footnotes · ownership attribution and instrument terms

F1: The reported securities and warrants are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F2: The reported securities and warrants are owned directly by JEB Partners, L.P. ("JEB Partners") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F3: The reported securities and warrants are directly owned by James E. Besser in his personal capacity.

F4: The reported warrants are exercisable as of the issue date, subject to certain conditions.

F5: The reported warrants expire at 5:00pm E.D.T. on the fourth anniversary of the issue date, subject to certain conditions.

F6: The reported warrants are subject to a blocker provision that prevents James E. Besser from exercising the warrants if he would be more than a 4.99% beneficial owner of the Common Stock, $0.001 par value, following such exercise. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to the Common Stock Purchase Warrant included as Exhibit 4.1 of the Issuer's 8-K filed on October 7, 2021, which is incorporated by reference.

Modular Medical, Inc.

Report date September 30, 2026 · Filed October 01, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1.95 · Expires 2026-09-30Direct62 Reported balance After 2026-09-30 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-09-30 · Grant · Acquired 62 · Balance 62

F1: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1.95 · Expires 2026-09-30Direct312 Reported balance After 2026-09-30 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-09-30 · Grant · Acquired 250 · Balance 312

F1: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Filing footnotes · ownership attribution and instrument terms

F1: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

NEUROONE MEDICAL TECHNOLOGIES Corp

Report date January 15, 2021 · Filed January 21, 2021

Jointly reported with BESSER JAMES E, MANCHESTER MANAGEMENT CO LLC, MANCHESTER MANAGEMENT PR, LLC, Manchester Explorer, L.P.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect492,951 Reported balance Holding disclosure · report date 2021-01-15 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 492,951

Common StockSEC Table I · non-derivativeIndirectSee Footnotes4,750,000 Reported balance Holding disclosure · report date 2021-01-15 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 4,750,000

F1: The reported securities and warrants are directly owned by Manchester Explorer, L.P. JEB Partners, L.P and by Morgan C. Frank in his personal capacity. The reported securities and warrants are indirectly beneficially owned by Manchester Management PR, LLC and Manchester Management Company, LLC as a result of having investment discretion over Manchester Explorer, L.P. and JEB Partners, L.P. The reported securities and warrants may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and Manchester Management Company, LLC and by Morgan C. Frank, who serves as a portfolio manager and as a consultant for Manchester Management Company, LLC.

F2: The Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.75 · Expires 2026-01-15DirectNot disclosed Reported balance Holding disclosure · report date 2021-01-15 · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · Balance Not disclosed

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.75 · Expires 2026-01-15IndirectSee FootnotesNot disclosed Reported balance Holding disclosure · report date 2021-01-15 · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · Balance Not disclosed

F1: The reported securities and warrants are directly owned by Manchester Explorer, L.P. JEB Partners, L.P and by Morgan C. Frank in his personal capacity. The reported securities and warrants are indirectly beneficially owned by Manchester Management PR, LLC and Manchester Management Company, LLC as a result of having investment discretion over Manchester Explorer, L.P. and JEB Partners, L.P. The reported securities and warrants may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and Manchester Management Company, LLC and by Morgan C. Frank, who serves as a portfolio manager and as a consultant for Manchester Management Company, LLC.

F2: The Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: The reported securities and warrants are directly owned by Manchester Explorer, L.P. JEB Partners, L.P and by Morgan C. Frank in his personal capacity. The reported securities and warrants are indirectly beneficially owned by Manchester Management PR, LLC and Manchester Management Company, LLC as a result of having investment discretion over Manchester Explorer, L.P. and JEB Partners, L.P. The reported securities and warrants may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and Manchester Management Company, LLC and by Morgan C. Frank, who serves as a portfolio manager and as a consultant for Manchester Management Company, LLC.

F2: The Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SANUWAVE Health, Inc.

Report date September 30, 2026 · Filed October 03, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.71 · Expires 2031-09-30Direct11,286 Reported balance After 2026-09-30 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-09-30 · Grant · Acquired 11,286 · Balance 11,286

F1: Options were fully vested at the grant date.

Filing footnotes · ownership attribution and instrument terms

F1: Options were fully vested at the grant date.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

FENNEC PHARMACEUTICALS INC.

Report date January 27, 2016 · Filed March 29, 2018

Jointly reported with MANCHESTER MANAGEMENT PR, LLC, MANCHESTER MANAGEMENT CO LLC, Manchester Explorer, L.P., BESSER JAMES E

Section 16 reporting ended · disclosed 2018-03-29. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee footnote1,666,666 Last balance in matching sequence After 2018-03-28 transaction · row 24 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
15 source rows

Row 1 · 2018-03-08 · Sale · Disposed 10,000 · Balance 2,146,797

F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Row 2 · 2018-03-12 · Sale · Disposed 18,560 · Balance 2,128,237

F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Row 3 · 2018-03-13 · Sale · Disposed 16,934 · Balance 2,111,303

F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Row 4 · 2018-03-14 · Sale · Disposed 13,600 · Balance 2,097,703

F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Row 5 · 2018-03-16 · Sale · Disposed 6,423 · Balance 2,091,280

F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Row 6 · 2018-03-16 · Sale · Disposed 2,120 · Balance 2,089,160

F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Row 8 · 2018-03-19 · Sale · Disposed 200 · Balance 2,088,960

F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Row 10 · 2018-03-20 · Sale · Disposed 4,200 · Balance 2,084,760

F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Row 12 · 2018-03-20 · Sale · Disposed 15,183 · Balance 2,069,577

F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Row 14 · 2018-03-21 · Sale · Disposed 210,311 · Balance 1,859,266

F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Row 16 · 2018-03-22 · Sale · Disposed 20,000 · Balance 1,839,266

F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Row 18 · 2018-03-23 · Sale · Disposed 3,500 · Balance 1,835,766

F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Row 20 · 2018-03-27 · Sale · Disposed 22,707 · Balance 1,813,059

F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Row 22 · 2018-03-28 · Sale · Disposed 605 · Balance 1,812,454

F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Row 24 · 2018-03-28 · Sale · Disposed 145,788 · Balance 1,666,666

F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Common StockSEC Table I · non-derivativeDirect1,250,000 Last balance in matching sequence After 2018-03-28 transaction · row 25 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
10 source rows

Row 7 · 2018-03-16 · Sale · Disposed 2,120 · Balance 1,672,494

F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Row 9 · 2018-03-19 · Sale · Disposed 200 · Balance 1,672,294

F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Row 11 · 2018-03-20 · Sale · Disposed 4,200 · Balance 1,668,094

F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Row 13 · 2018-03-20 · Sale · Disposed 15,183 · Balance 1,652,911

F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Row 15 · 2018-03-21 · Sale · Disposed 210,311 · Balance 1,442,600

F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Row 17 · 2018-03-22 · Sale · Disposed 20,000 · Balance 1,422,600

F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Row 19 · 2018-03-23 · Sale · Disposed 3,500 · Balance 1,419,100

F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Row 21 · 2018-03-27 · Sale · Disposed 22,707 · Balance 1,396,393

F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Row 23 · 2018-03-28 · Sale · Disposed 605 · Balance 1,395,788

F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Row 25 · 2018-03-28 · Sale · Disposed 145,788 · Balance 1,250,000

F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Filing footnotes · ownership attribution and instrument terms

F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

FiEE, Inc.

Report date August 03, 2020 · Filed August 05, 2020

Jointly reported with MANCHESTER MANAGEMENT CO LLC, Manchester Explorer, L.P., BESSER JAMES E

Section 16 reporting ended · disclosed 2020-08-05. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, $0.01 par valueSEC Table I · non-derivativeIndirectSee footnote0 Reported balance After 2020-08-03 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2020-08-03 · Sale · Disposed 4,287,214 · Balance 0

F1: Manchester Management Company, LLC, a Delaware limited liability company ("Manchester"), is principally engaged in the business of providing investment management services. The reported securities are indirectly beneficially owned by Manchester as a result of it having investment discretion over certain advisory accounts it manages, including Manchester Explorer, L.P. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester, and by Morgan C. Frank, who serves as a portfolio manager and as a consultant for Manchester. Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Common Stock, $0.01 par valueSEC Table I · non-derivativeDirect0 Reported balance After 2020-08-03 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 2 · 2020-08-03 · Sale · Disposed 2,857,643 · Balance 0

F2: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Common Stock, $0.01 par valueSEC Table I · non-derivativeDirect0 Reported balance After 2020-08-03 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 3 · 2020-08-03 · Sale · Disposed 143,357 · Balance 0

F3: The reported securities are directly owned by James E. Besser in his personal capacity.

Common Stock, $0.01 par valueSEC Table I · non-derivativeDirect0 Reported balance After 2020-08-03 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 4 · 2020-08-03 · Sale · Disposed 142,857 · Balance 0

F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.

Filing footnotes · ownership attribution and instrument terms

F1: Manchester Management Company, LLC, a Delaware limited liability company ("Manchester"), is principally engaged in the business of providing investment management services. The reported securities are indirectly beneficially owned by Manchester as a result of it having investment discretion over certain advisory accounts it manages, including Manchester Explorer, L.P. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester, and by Morgan C. Frank, who serves as a portfolio manager and as a consultant for Manchester. Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F2: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

F3: The reported securities are directly owned by James E. Besser in his personal capacity.

F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 30, 2022 Filed Oct 3, 2022 18:54 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 1,875 $4.34 Strike: $4.34 $8,137.50
Disclosure

SEC source: 0001019056-22-000612 · frank.xml · derivative · entry 1

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,875

Underlying: Common Stock · 1,875 shares

Expires 2032-09-30

F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
July 19, 2022 Filed Aug 8, 2022 20:19 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 7,500 $5.16 Strike: $5.16 $38,700.00
Disclosure

SEC source: 0001019056-22-000542 · frank.xml · derivative · entry 2

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2032-07-19

F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
June 30, 2022 Filed Aug 8, 2022 20:19 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 3,634 $5.16 Strike: $5.16 $18,751.44
Disclosure

SEC source: 0001019056-22-000542 · frank.xml · derivative · entry 1

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,634

Underlying: Common Stock · 3,634 shares

Expires 2032-06-30

F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
March 31, 2022 Filed Apr 4, 2022 21:01 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 17,943 $4.18 Strike: $4.18 $75,001.74
Disclosure

SEC source: 0001019056-22-000312 · frank.xml · derivative · entry 2

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,943

Underlying: Common Stock · 17,943 shares

Expires 2032-03-31

F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grants reported herein, the Reporting Person currently has aggregate options to purchase a total of 90,325 shares of the Issuer.

Read SEC document
March 31, 2022 Filed Apr 4, 2022 21:01 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 4,486 $4.18 Strike: $4.18 $18,751.48
Disclosure

SEC source: 0001019056-22-000312 · frank.xml · derivative · entry 1

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,486

Underlying: Common Stock · 4,486 shares

Expires 2032-03-31

F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grants reported herein, the Reporting Person currently has aggregate options to purchase a total of 90,325 shares of the Issuer.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 23:54 UTC Modular Medical, Inc. MODD · Entity 7488 Exercise / conversionCommon Stock Purchase Warrant · Derivative 234,274 Not disclosed Strike: $6.60 Not disclosed
Disclosure

SEC source: 0000919574-22-001710 · ownership.xml · derivative · entry 6

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnote

Disclosed balance after: 234,274

Underlying: Common Stock, par value $0.001 per share · 234,274 shares

Expires 2027-02-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The reported securities were obtained due to the conversion of a Convertible Promissory Note (the "Note"). The Note was convertible into an equal amounts of shares of Common Stock, par value $0.001 per share and Common Stock Purchase Warrants at a conversion price equal to the sum of principal and accrued interest multiplied by 1.25. The principal amount of the Note was $1,026,630 and the Note had accrued $97,881 of interest. The total principal and interest was then multiplied by 1.25 resulting in a conversion value of $1,405,639. This translated to 234,274 shares of Common Stock, par value $0.001 per share and 234,274 Common Stock Purchase Warrants based upon a $6.00 purchase price. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference.

F2 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 23:54 UTC Modular Medical, Inc. MODD · Entity 7488 Exercise / conversionConvertible Promissory Note · Derivative 1,000,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000919574-22-001710 · ownership.xml · derivative · entry 5

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnote

Disclosed balance after: 0

Underlying: Common Stock, par value $0.001 per share; Warrant · Not disclosed shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The reported securities were obtained due to the conversion of a Convertible Promissory Note (the "Note"). The Note was convertible into an equal amounts of shares of Common Stock, par value $0.001 per share and Common Stock Purchase Warrants at a conversion price equal to the sum of principal and accrued interest multiplied by 1.25. The principal amount of the Note was $1,026,630 and the Note had accrued $97,881 of interest. The total principal and interest was then multiplied by 1.25 resulting in a conversion value of $1,405,639. This translated to 234,274 shares of Common Stock, par value $0.001 per share and 234,274 Common Stock Purchase Warrants based upon a $6.00 purchase price. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference.

F1 · price: The reported securities were obtained due to the conversion of a Convertible Promissory Note (the "Note"). The Note was convertible into an equal amounts of shares of Common Stock, par value $0.001 per share and Common Stock Purchase Warrants at a conversion price equal to the sum of principal and accrued interest multiplied by 1.25. The principal amount of the Note was $1,026,630 and the Note had accrued $97,881 of interest. The total principal and interest was then multiplied by 1.25 resulting in a conversion value of $1,405,639. This translated to 234,274 shares of Common Stock, par value $0.001 per share and 234,274 Common Stock Purchase Warrants based upon a $6.00 purchase price. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference.

F1 · derivative.exercise_date: The reported securities were obtained due to the conversion of a Convertible Promissory Note (the "Note"). The Note was convertible into an equal amounts of shares of Common Stock, par value $0.001 per share and Common Stock Purchase Warrants at a conversion price equal to the sum of principal and accrued interest multiplied by 1.25. The principal amount of the Note was $1,026,630 and the Note had accrued $97,881 of interest. The total principal and interest was then multiplied by 1.25 resulting in a conversion value of $1,405,639. This translated to 234,274 shares of Common Stock, par value $0.001 per share and 234,274 Common Stock Purchase Warrants based upon a $6.00 purchase price. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference.

F1 · derivative.expiration_date: The reported securities were obtained due to the conversion of a Convertible Promissory Note (the "Note"). The Note was convertible into an equal amounts of shares of Common Stock, par value $0.001 per share and Common Stock Purchase Warrants at a conversion price equal to the sum of principal and accrued interest multiplied by 1.25. The principal amount of the Note was $1,026,630 and the Note had accrued $97,881 of interest. The total principal and interest was then multiplied by 1.25 resulting in a conversion value of $1,405,639. This translated to 234,274 shares of Common Stock, par value $0.001 per share and 234,274 Common Stock Purchase Warrants based upon a $6.00 purchase price. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference.

F1 · derivative.underlying_shares: The reported securities were obtained due to the conversion of a Convertible Promissory Note (the "Note"). The Note was convertible into an equal amounts of shares of Common Stock, par value $0.001 per share and Common Stock Purchase Warrants at a conversion price equal to the sum of principal and accrued interest multiplied by 1.25. The principal amount of the Note was $1,026,630 and the Note had accrued $97,881 of interest. The total principal and interest was then multiplied by 1.25 resulting in a conversion value of $1,405,639. This translated to 234,274 shares of Common Stock, par value $0.001 per share and 234,274 Common Stock Purchase Warrants based upon a $6.00 purchase price. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference.

F2 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 23:54 UTC Modular Medical, Inc. MODD · Entity 7488 Exercise / conversionCommon Stock, par value $0.001 per share 234,274 Not disclosed Not disclosed
Disclosure

SEC source: 0000919574-22-001710 · ownership.xml · nonDerivative · entry 1

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnote

Disclosed balance after: 2,218,077

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The reported securities were obtained due to the conversion of a Convertible Promissory Note (the "Note"). The Note was convertible into an equal amounts of shares of Common Stock, par value $0.001 per share and Common Stock Purchase Warrants at a conversion price equal to the sum of principal and accrued interest multiplied by 1.25. The principal amount of the Note was $1,026,630 and the Note had accrued $97,881 of interest. The total principal and interest was then multiplied by 1.25 resulting in a conversion value of $1,405,639. This translated to 234,274 shares of Common Stock, par value $0.001 per share and 234,274 Common Stock Purchase Warrants based upon a $6.00 purchase price. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference.

F2 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
February 10, 2022 Filed Feb 15, 2022 01:15 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock Purchase Warrant · Derivative 300,000 Not disclosed Strike: $6.60 Not disclosed
Disclosure

SEC source: 0000919574-22-001656 · ownership.xml · derivative · entry 5

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnote

Disclosed balance after: 300,000

Underlying: Common Stock, par value $0.001 per share · 300,000 shares

Expires 2027-02-10

F1 · price: Manchester Management Company, LLC ("Manchester Management") acquired 300,000 units consisting of one share of Common Stock, par value $0.001 per share and one warrant to purchase one share of Common Stock, par value $0.001 per share.

F2 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
February 10, 2022 Filed Feb 15, 2022 01:15 UTC Modular Medical, Inc. MODD · Entity 7488 PurchaseCommon Stock, par value $0.001 per share 300,000 $6.00 $1,800,000.00
Disclosure

SEC source: 0000919574-22-001656 · ownership.xml · nonDerivative · entry 1

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnote

Disclosed balance after: 1,983,803

F1 · price: Manchester Management Company, LLC ("Manchester Management") acquired 300,000 units consisting of one share of Common Stock, par value $0.001 per share and one warrant to purchase one share of Common Stock, par value $0.001 per share.

F2 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
December 31, 2021 Filed Jan 3, 2022 11:05 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 2,497 $7.51 Strike: $7.51 $18,752.47
Disclosure

SEC source: 0001019056-22-000008 · frank.xml · derivative · entry 2

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,497

Underlying: Common Stock · 2,497 shares

Expires 2031-12-31

F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grants reported herein, the Reporting Person currently has aggregate options to purchase a total of 67,896 shares of the Issuer.

Read SEC document
December 31, 2021 Filed Jan 3, 2022 11:05 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 9,987 $7.51 Strike: $7.51 $75,002.37
Disclosure

SEC source: 0001019056-22-000008 · frank.xml · derivative · entry 1

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,987

Underlying: Common Stock · 9,987 shares

Expires 2031-12-31

F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grants reported herein, the Reporting Person currently has aggregate options to purchase a total of 67,896 shares of the Issuer.

Read SEC document
September 30, 2021 Filed Oct 4, 2021 17:29 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 6,292 $2.98 Strike: $2.98 $18,750.16
Disclosure

SEC source: 0001019056-21-000521 · frank.xml · derivative · entry 2

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,292

Underlying: Common Stock · 6,292 shares

Expires 2031-09-30

F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grants reported herein, the Reporting Person currently has aggregate options to purchase a total of 197,350 shares of the Issuer.

Read SEC document
September 30, 2021 Filed Oct 4, 2021 17:29 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 25,168 $2.98 Strike: $2.98 $75,000.64
Disclosure

SEC source: 0001019056-21-000521 · frank.xml · derivative · entry 1

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,168

Underlying: Common Stock · 25,168 shares

Expires 2031-09-30

F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grants reported herein, the Reporting Person currently has aggregate options to purchase a total of 197,350 shares of the Issuer.

Read SEC document
June 30, 2021 Filed Jul 2, 2021 19:37 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 3,178 $5.90 Strike: $5.90 $18,750.20
Disclosure

SEC source: 0001019056-21-000403 · frank.xml · derivative · entry 2

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,890

Underlying: Common Stock · 3,178 shares

Expires 2031-06-30

F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grants reported herein, the Reporting Person currently has aggregate options to purchase a total of 165,890 shares of the Issuer.

Read SEC document
June 30, 2021 Filed Jul 2, 2021 19:37 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 12,712 $5.90 Strike: $5.90 $75,000.80
Disclosure

SEC source: 0001019056-21-000403 · frank.xml · derivative · entry 1

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,712

Underlying: Common Stock · 12,712 shares

Expires 2031-06-30

F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grants reported herein, the Reporting Person currently has aggregate options to purchase a total of 165,890 shares of the Issuer.

Read SEC document
May 11, 2021 Filed Oct 29, 2021 22:43 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock Pur-chase Warrant · Derivative 379,174 Not disclosed Strike: $2.87 Not disclosed
Disclosure

SEC source: 0000919574-21-006530 · ownership.xml · derivative · entry 8

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner · Director by Deputization

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner · Director by Deputization

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 379,174

Underlying: Common Stock, par value $0.001 per share · Not disclosed shares

Expires 2027-02-06

F8 · price: The Common Stock Purchase Warrant (the "Warrant") entitles the holder of the warrant to shares of Common Stock equal to the principal amount of the Note divided by $2.87. The Warrants are not convertible until 271 days after the issue date. The foregoing description of the Warrant does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Common Stock Purchase Warrant included as Exhibit 10.22 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference.

F8 · derivative.underlying_shares: The Common Stock Purchase Warrant (the "Warrant") entitles the holder of the warrant to shares of Common Stock equal to the principal amount of the Note divided by $2.87. The Warrants are not convertible until 271 days after the issue date. The foregoing description of the Warrant does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Common Stock Purchase Warrant included as Exhibit 10.22 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference.

F1 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
May 11, 2021 Filed Oct 29, 2021 22:43 UTC Modular Medical, Inc. MODD · Entity 7488 GrantConvertible Promissory Note · Derivative 1,000,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000919574-21-006530 · ownership.xml · derivative · entry 7

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner · Director by Deputization

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner · Director by Deputization

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,000,000

Underlying: Common Stock, par value $0.001 per share · Not disclosed shares

Expires not disclosed

F6 · derivative.exercise_price: On May 11, 2021, the Note was converted into the May 2021 Convertible Promissory Note ("May Note"). The May Note is convertible upon (i) an offering of common stock or other securities ("Qualified Capital Raise") with total proceeds to the Issuer of not less than $12,000,000, or (ii) at any time following the day 271 days after the issue date. The May Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the sum of principal and accrued interest shall be multiplied by 1.25; e.g., $1,000 of principal which had accrued $60 of interest would be treated as if it were ($1,000 + $60) = $1,060 X 1.25 = $1,325 of capital invested in the Qualified Capital Raise for the purposes of determining the number of securities issued.

F7 · derivative.exercise_price: (6 continued) The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference.

F6 · kind: On May 11, 2021, the Note was converted into the May 2021 Convertible Promissory Note ("May Note"). The May Note is convertible upon (i) an offering of common stock or other securities ("Qualified Capital Raise") with total proceeds to the Issuer of not less than $12,000,000, or (ii) at any time following the day 271 days after the issue date. The May Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the sum of principal and accrued interest shall be multiplied by 1.25; e.g., $1,000 of principal which had accrued $60 of interest would be treated as if it were ($1,000 + $60) = $1,060 X 1.25 = $1,325 of capital invested in the Qualified Capital Raise for the purposes of determining the number of securities issued.

F7 · kind: (6 continued) The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference.

F6 · price: On May 11, 2021, the Note was converted into the May 2021 Convertible Promissory Note ("May Note"). The May Note is convertible upon (i) an offering of common stock or other securities ("Qualified Capital Raise") with total proceeds to the Issuer of not less than $12,000,000, or (ii) at any time following the day 271 days after the issue date. The May Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the sum of principal and accrued interest shall be multiplied by 1.25; e.g., $1,000 of principal which had accrued $60 of interest would be treated as if it were ($1,000 + $60) = $1,060 X 1.25 = $1,325 of capital invested in the Qualified Capital Raise for the purposes of determining the number of securities issued.

F7 · price: (6 continued) The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference.

F6 · derivative.exercise_date: On May 11, 2021, the Note was converted into the May 2021 Convertible Promissory Note ("May Note"). The May Note is convertible upon (i) an offering of common stock or other securities ("Qualified Capital Raise") with total proceeds to the Issuer of not less than $12,000,000, or (ii) at any time following the day 271 days after the issue date. The May Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the sum of principal and accrued interest shall be multiplied by 1.25; e.g., $1,000 of principal which had accrued $60 of interest would be treated as if it were ($1,000 + $60) = $1,060 X 1.25 = $1,325 of capital invested in the Qualified Capital Raise for the purposes of determining the number of securities issued.

F7 · derivative.exercise_date: (6 continued) The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference.

F6 · derivative.expiration_date: On May 11, 2021, the Note was converted into the May 2021 Convertible Promissory Note ("May Note"). The May Note is convertible upon (i) an offering of common stock or other securities ("Qualified Capital Raise") with total proceeds to the Issuer of not less than $12,000,000, or (ii) at any time following the day 271 days after the issue date. The May Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the sum of principal and accrued interest shall be multiplied by 1.25; e.g., $1,000 of principal which had accrued $60 of interest would be treated as if it were ($1,000 + $60) = $1,060 X 1.25 = $1,325 of capital invested in the Qualified Capital Raise for the purposes of determining the number of securities issued.

F6 · derivative.underlying_shares: On May 11, 2021, the Note was converted into the May 2021 Convertible Promissory Note ("May Note"). The May Note is convertible upon (i) an offering of common stock or other securities ("Qualified Capital Raise") with total proceeds to the Issuer of not less than $12,000,000, or (ii) at any time following the day 271 days after the issue date. The May Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the sum of principal and accrued interest shall be multiplied by 1.25; e.g., $1,000 of principal which had accrued $60 of interest would be treated as if it were ($1,000 + $60) = $1,060 X 1.25 = $1,325 of capital invested in the Qualified Capital Raise for the purposes of determining the number of securities issued.

F7 · derivative.underlying_shares: (6 continued) The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference.

F1 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
May 11, 2021 Filed Oct 29, 2021 22:43 UTC Modular Medical, Inc. MODD · Entity 7488 Disposition to issuerConvertible Promissory Note · Derivative 1,000,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000919574-21-006530 · ownership.xml · derivative · entry 6

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner · Director by Deputization

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner · Director by Deputization

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock, par value $0.001 per share · Not disclosed shares

Expires not disclosed

F5 · derivative.exercise_price: On February 8, 2021, the Issuer completed an initial offering of the Convertible Promissory Note (the "Note"). The Note is convertible upon an equity financing with total proceeds to the Issuer of not less than $5,000,000. The Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the lowest cash price paid per share for equity securities by the investors in the equity financing multiplied by 0.80. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 10-Q filed on February 12, 2021, which is incorporated by reference.

F6 · kind: On May 11, 2021, the Note was converted into the May 2021 Convertible Promissory Note ("May Note"). The May Note is convertible upon (i) an offering of common stock or other securities ("Qualified Capital Raise") with total proceeds to the Issuer of not less than $12,000,000, or (ii) at any time following the day 271 days after the issue date. The May Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the sum of principal and accrued interest shall be multiplied by 1.25; e.g., $1,000 of principal which had accrued $60 of interest would be treated as if it were ($1,000 + $60) = $1,060 X 1.25 = $1,325 of capital invested in the Qualified Capital Raise for the purposes of determining the number of securities issued.

F7 · kind: (6 continued) The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference.

F6 · price: On May 11, 2021, the Note was converted into the May 2021 Convertible Promissory Note ("May Note"). The May Note is convertible upon (i) an offering of common stock or other securities ("Qualified Capital Raise") with total proceeds to the Issuer of not less than $12,000,000, or (ii) at any time following the day 271 days after the issue date. The May Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the sum of principal and accrued interest shall be multiplied by 1.25; e.g., $1,000 of principal which had accrued $60 of interest would be treated as if it were ($1,000 + $60) = $1,060 X 1.25 = $1,325 of capital invested in the Qualified Capital Raise for the purposes of determining the number of securities issued.

F7 · price: (6 continued) The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference.

F5 · derivative.exercise_date: On February 8, 2021, the Issuer completed an initial offering of the Convertible Promissory Note (the "Note"). The Note is convertible upon an equity financing with total proceeds to the Issuer of not less than $5,000,000. The Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the lowest cash price paid per share for equity securities by the investors in the equity financing multiplied by 0.80. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 10-Q filed on February 12, 2021, which is incorporated by reference.

F5 · derivative.expiration_date: On February 8, 2021, the Issuer completed an initial offering of the Convertible Promissory Note (the "Note"). The Note is convertible upon an equity financing with total proceeds to the Issuer of not less than $5,000,000. The Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the lowest cash price paid per share for equity securities by the investors in the equity financing multiplied by 0.80. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 10-Q filed on February 12, 2021, which is incorporated by reference.

F5 · derivative.underlying_shares: On February 8, 2021, the Issuer completed an initial offering of the Convertible Promissory Note (the "Note"). The Note is convertible upon an equity financing with total proceeds to the Issuer of not less than $5,000,000. The Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the lowest cash price paid per share for equity securities by the investors in the equity financing multiplied by 0.80. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 10-Q filed on February 12, 2021, which is incorporated by reference.

F1 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
February 08, 2021 Filed Oct 29, 2021 22:43 UTC Modular Medical, Inc. MODD · Entity 7488 PurchaseConvertible Promissory Note · Derivative 1,000,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000919574-21-006530 · ownership.xml · derivative · entry 5

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner · Director by Deputization

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner · Director by Deputization

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,000,000

Underlying: Common Stock, par value $0.001 per share · Not disclosed shares

Expires not disclosed

F5 · derivative.exercise_price: On February 8, 2021, the Issuer completed an initial offering of the Convertible Promissory Note (the "Note"). The Note is convertible upon an equity financing with total proceeds to the Issuer of not less than $5,000,000. The Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the lowest cash price paid per share for equity securities by the investors in the equity financing multiplied by 0.80. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 10-Q filed on February 12, 2021, which is incorporated by reference.

F5 · kind: On February 8, 2021, the Issuer completed an initial offering of the Convertible Promissory Note (the "Note"). The Note is convertible upon an equity financing with total proceeds to the Issuer of not less than $5,000,000. The Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the lowest cash price paid per share for equity securities by the investors in the equity financing multiplied by 0.80. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 10-Q filed on February 12, 2021, which is incorporated by reference.

F5 · price: On February 8, 2021, the Issuer completed an initial offering of the Convertible Promissory Note (the "Note"). The Note is convertible upon an equity financing with total proceeds to the Issuer of not less than $5,000,000. The Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the lowest cash price paid per share for equity securities by the investors in the equity financing multiplied by 0.80. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 10-Q filed on February 12, 2021, which is incorporated by reference.

F5 · derivative.exercise_date: On February 8, 2021, the Issuer completed an initial offering of the Convertible Promissory Note (the "Note"). The Note is convertible upon an equity financing with total proceeds to the Issuer of not less than $5,000,000. The Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the lowest cash price paid per share for equity securities by the investors in the equity financing multiplied by 0.80. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 10-Q filed on February 12, 2021, which is incorporated by reference.

F5 · derivative.expiration_date: On February 8, 2021, the Issuer completed an initial offering of the Convertible Promissory Note (the "Note"). The Note is convertible upon an equity financing with total proceeds to the Issuer of not less than $5,000,000. The Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the lowest cash price paid per share for equity securities by the investors in the equity financing multiplied by 0.80. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 10-Q filed on February 12, 2021, which is incorporated by reference.

F5 · derivative.underlying_shares: On February 8, 2021, the Issuer completed an initial offering of the Convertible Promissory Note (the "Note"). The Note is convertible upon an equity financing with total proceeds to the Issuer of not less than $5,000,000. The Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the lowest cash price paid per share for equity securities by the investors in the equity financing multiplied by 0.80. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 10-Q filed on February 12, 2021, which is incorporated by reference.

F1 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
November 30, 2020 Filed Oct 29, 2021 22:43 UTC Modular Medical, Inc. MODD · Entity 7488 PurchaseCommon Stock, par value $0.001 per share 34,843 $2.87 $99,999.41
Disclosure

SEC source: 0000919574-21-006530 · ownership.xml · nonDerivative · entry 3

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner · Director by Deputization

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner · Director by Deputization

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 304,562

F3 · ownership.direct: The reported securities are directly owned by James E. Besser in his personal capacity.

Read SEC document
August 03, 2020 Filed Aug 5, 2020 21:05 UTC FiEE, Inc. ZMTP · Entity 7395 SaleCommon Stock, $0.01 par value 142,857 $1.95 $278,571.15
Disclosure

SEC source: 0000919574-20-004833 · ownership.xml · nonDerivative · entry 4

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F4 · ownership.direct: The reported securities are directly owned by Morgan C. Frank in his personal capacity.

Read SEC document
August 03, 2020 Filed Aug 5, 2020 21:05 UTC FiEE, Inc. ZMTP · Entity 7395 SaleCommon Stock, $0.01 par value 143,357 $1.95 $279,546.15
Disclosure

SEC source: 0000919574-20-004833 · ownership.xml · nonDerivative · entry 3

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F3 · ownership.direct: The reported securities are directly owned by James E. Besser in his personal capacity.

Read SEC document
August 03, 2020 Filed Aug 5, 2020 21:05 UTC FiEE, Inc. ZMTP · Entity 7395 SaleCommon Stock, $0.01 par value 2,857,643 $1.95 $5,572,403.85
Disclosure

SEC source: 0000919574-20-004833 · ownership.xml · nonDerivative · entry 2

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Read SEC document
August 03, 2020 Filed Aug 5, 2020 21:05 UTC FiEE, Inc. ZMTP · Entity 7395 SaleCommon Stock, $0.01 par value 4,287,214 $1.95 $8,360,067.30
Disclosure

SEC source: 0000919574-20-004833 · ownership.xml · nonDerivative · entry 1

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company ("Manchester"), is principally engaged in the business of providing investment management services. The reported securities are indirectly beneficially owned by Manchester as a result of it having investment discretion over certain advisory accounts it manages, including Manchester Explorer, L.P. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester, and by Morgan C. Frank, who serves as a portfolio manager and as a consultant for Manchester. Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
June 30, 2020 Filed Oct 29, 2021 22:43 UTC Modular Medical, Inc. MODD · Entity 7488 PurchaseCommon Stock, par value $0.001 per share 104,529 $2.87 $299,998.23
Disclosure

SEC source: 0000919574-21-006530 · ownership.xml · nonDerivative · entry 2

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner · Director by Deputization

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner · Director by Deputization

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,022,105

F2 · ownership.nature: The reported securities are owned directly by JEB Partners, L.P. ("JEB Partners") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
June 30, 2020 Filed Oct 29, 2021 22:43 UTC Modular Medical, Inc. MODD · Entity 7488 PurchaseCommon Stock, par value $0.001 per share 34,843 $2.87 $99,999.41
Disclosure

SEC source: 0000919574-21-006530 · ownership.xml · nonDerivative · entry 1

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner · Director by Deputization

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner · Director by Deputization

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 5,051,409

F1 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
May 12, 2020 Filed May 19, 2020 17:03 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 150,000 $2.87 Strike: $2.87 $430,500.00
Disclosure

SEC source: 0001019056-20-000351 · frank.xml · derivative · entry 1

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2030-05-12

F1 · security: This option will vest as to one-third of the shares subject to the option on each annual anniversary of January 1, 2020.

Read SEC document
November 20, 2018 Filed Nov 20, 2018 23:11 UTC Modular Medical, Inc. MODD · Entity 7488 PurchaseCommon Stock, par value $0.001 per share 720,001 $2.25 $1,620,002.25
Disclosure

SEC source: 0000919574-18-007647 · ownership.xml · nonDerivative · entry 1

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · ownership.direct: This Form 4 is being filed by Manchester Explorer, L.P. ("Explorer"), Manchester Management Company, LLC ("MMC"), James E. Besser and Morgan C. Frank as 10% Owners. MMC, provides investment management services to Explorer and other clients. The reported securities may be deemed indirectly beneficially owned by MMC as a result of it being the general partner of Explorer and such other clients. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of MMC and by Morgan C. Frank, who serves as a portfolio manager and a consultant of MMC. Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act.

F2 · ownership.direct: The reported 720,001 shares consists of (i) 471,112 shares purchased by Explorer, (ii) 160,000 shares purchased by another client of MMC, and (iii) 88,889 shares purchased by Mr. Besser.

Read SEC document
November 20, 2018 Filed Oct 29, 2021 22:32 UTC Amendment Modular Medical, Inc. MODD · Entity 7488 PurchaseCommon Stock, par value $0.001 per share 160,000 $2.25 $360,000.00
Disclosure

SEC source: 0000919574-21-006529 · ownership.xml · nonDerivative · entry 4

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 917,576

F4 · ownership.nature: The reported securities are owned directly by JEB Partners, L.P. ("JEB Partners") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
November 20, 2018 Filed Oct 29, 2021 22:32 UTC Amendment Modular Medical, Inc. MODD · Entity 7488 PurchaseCommon Stock, par value $0.001 per share 471,111 $2.25 $1,059,999.75
Disclosure

SEC source: 0000919574-21-006529 · ownership.xml · nonDerivative · entry 3

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 5,016,566

F3 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
November 20, 2018 Filed Oct 29, 2021 22:32 UTC Amendment Modular Medical, Inc. MODD · Entity 7488 PurchaseCommon Stock, par value $0.001 per share 88,889 $2.25 $200,000.25
Disclosure

SEC source: 0000919574-21-006529 · ownership.xml · nonDerivative · entry 1

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 269,719

F1 · ownership.direct: The reported securities are directly owned by James E. Besser in his personal capacity.

Read SEC document
March 28, 2018 Filed Mar 29, 2018 21:10 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 SaleCommon Stock 145,788 $11.50 $1,676,562.00
Disclosure

SEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 25

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250,000

F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Read SEC document
March 28, 2018 Filed Mar 29, 2018 21:10 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 SaleCommon Stock 145,788 $11.50 $1,676,562.00
Disclosure

SEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 24

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,666,666

F1 · ownership.nature: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
March 28, 2018 Filed Mar 29, 2018 21:10 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 SaleCommon Stock 605 $11.65 $7,048.25
Disclosure

SEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 23

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,395,788

F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Read SEC document
March 28, 2018 Filed Mar 29, 2018 21:10 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 SaleCommon Stock 605 $11.65 $7,048.25
Disclosure

SEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 22

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,812,454

F1 · ownership.nature: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
March 27, 2018 Filed Mar 29, 2018 21:10 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 SaleCommon Stock 22,707 $11.34 $257,497.38
Disclosure

SEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 21

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,396,393

F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Read SEC document
March 27, 2018 Filed Mar 29, 2018 21:10 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 SaleCommon Stock 22,707 $11.34 $257,497.38
Disclosure

SEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 20

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,813,059

F1 · ownership.nature: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
March 23, 2018 Filed Mar 29, 2018 21:10 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 SaleCommon Stock 3,500 $10.88 $38,080.00
Disclosure

SEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 19

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,419,100

F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Read SEC document
March 23, 2018 Filed Mar 29, 2018 21:10 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 SaleCommon Stock 3,500 $10.88 $38,080.00
Disclosure

SEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 18

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,835,766

F1 · ownership.nature: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
March 22, 2018 Filed Mar 29, 2018 21:10 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 SaleCommon Stock 20,000 $10.76 $215,200.00
Disclosure

SEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 17

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,422,600

F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Read SEC document
March 22, 2018 Filed Mar 29, 2018 21:10 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 SaleCommon Stock 20,000 $10.76 $215,200.00
Disclosure

SEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 16

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,839,266

F1 · ownership.nature: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
March 21, 2018 Filed Mar 29, 2018 21:10 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 SaleCommon Stock 210,311 $10.18 $2,140,965.98
Disclosure

SEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 15

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,442,600

F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Read SEC document
March 21, 2018 Filed Mar 29, 2018 21:10 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 SaleCommon Stock 210,311 $10.18 $2,140,965.98
Disclosure

SEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 14

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,859,266

F1 · ownership.nature: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
March 20, 2018 Filed Mar 29, 2018 21:10 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 SaleCommon Stock 15,183 $9.70 $147,275.10
Disclosure

SEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 13

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,652,911

F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Read SEC document
March 20, 2018 Filed Mar 29, 2018 21:10 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 SaleCommon Stock 15,183 $9.70 $147,275.10
Disclosure

SEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 12

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,069,577

F1 · ownership.nature: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
March 20, 2018 Filed Mar 29, 2018 21:10 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 SaleCommon Stock 4,200 $9.54 $40,068.00
Disclosure

SEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 11

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,668,094

F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Read SEC document
March 20, 2018 Filed Mar 29, 2018 21:10 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 SaleCommon Stock 4,200 $9.54 $40,068.00
Disclosure

SEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 10

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,084,760

F1 · ownership.nature: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
March 19, 2018 Filed Mar 29, 2018 21:10 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 SaleCommon Stock 200 $9.57 $1,914.00
Disclosure

SEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 9

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,672,294

F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.

Read SEC document
March 19, 2018 Filed Mar 29, 2018 21:10 UTC FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 SaleCommon Stock 200 $9.57 $1,914.00
Disclosure

SEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 8

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · 10% owner

BESSER JAMES E · CIK 0001512127 · 10% owner

FRANK MORGAN C. · CIK 0001593072 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,088,960

F1 · ownership.nature: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.

F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.